Periodic fever-infantile enterocolitis-autoinflammatory syndrome (AIFEC): A Patient Guide

Periodic fever-infantile enterocolitis-autoinflammatory syndrome (AIFEC) is an ultra-rare genetic condition where the immune system’s internal alarm is permanently stuck in the “on” position. This is caused by a mutation in the NLRC4 gene, which normally tells the body how to build a sensor that detects bacteria. In a child with AIFEC, this sensor is overactive, triggering a cascade of inflammation that primarily attacks the digestive tract and causes high, recurring fevers ^[1][2]. Because it is so rare and its symptoms—like severe diarrhea and fever—closely mirror common childhood infections or allergies, families often face a long and difficult path to the correct diagnosis ^[3]. (In some medical settings, this may also be referred to as PFIT).

The disease behaves unpredictably, often beginning in the first few weeks of life with intense bowel inflammation, known as enterocolitis. While it is a chronic condition that requires lifelong management, the way it shows up can vary from daily digestive struggles to sudden, life-threatening “cytokine storms” such as Macrophage Activation Syndrome (MAS) or shock ^[4][5]. Living with AIFEC means maintaining a high level of vigilance, learning to recognize when a typical flare has escalated into an emergency that requires immediate medical intervention ^[1].

Managing AIFEC requires a specialized team of doctors, including rheumatologists, immunologists, and gastroenterologists, who work together to “quiet” the overactive immune system. Treatment is highly individualized and focuses on blocking specific inflammatory proteins, such as IL-1 and IL-18, while providing intensive nutritional support to help the gut heal ^[6][7]. Although finding the right combination of therapies often involves a period of trial and error, the goal is to move beyond managing crises toward a more stable life where the child can grow ^[8].

While an AIFEC diagnosis can feel overwhelming, you are now equipped with the specific biological name for your child’s struggle. This clarity allows your medical team to move away from broad treatments and toward targeted therapies that address the inflammatory pathways. While these therapies do not correct the underlying genetic mutation, with the right care team and a proactive monitoring plan, it is possible to gain control over the “stuck” alarm system and focus on supporting your child’s well-being and future ^[9].